Helpful Resources for CIDP Patients
https://pixabay.com/en/circle-community-hands-holding-159252/

Helpful Resources for CIDP Patients

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease that affects the nervous system. It causes peripheral nerves and nerve roots (the sites where nerves are attached to the central…

Continue Reading Helpful Resources for CIDP Patients
Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
cocoparisienne / Pixabay

Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

According to a story from WebMD, the rare nervous system disorder chronic inflammatory demyelinating polyneuropathy is notorious for being difficult to diagnose. Many rare diseases can be challenging to identify.…

Continue Reading Why is it Difficult to Diagnose Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?
Chronic Inflammatory Demyelinating Polyneuropathy Didn’t Stop This Woman From Finishing Her 11th Chicago Marathon
skeeze / Pixabay

Chronic Inflammatory Demyelinating Polyneuropathy Didn’t Stop This Woman From Finishing Her 11th Chicago Marathon

According to a story from ESPN, there were times when Lynn Rogers wasn't sure if she was going to be able walk, much less run, ever again, but she wound…

Continue Reading Chronic Inflammatory Demyelinating Polyneuropathy Didn’t Stop This Woman From Finishing Her 11th Chicago Marathon
After a Dangerous Accident and CIDP, a Girl Shows her Courage
source: pixabay.com

After a Dangerous Accident and CIDP, a Girl Shows her Courage

According to a story from the Chillicothe Gazette, twelve-year-old Brooke Hopkins has already had to face chronic inflammatory demyelinating polyneuropathy and a devastating injury in her young life. However, through…

Continue Reading After a Dangerous Accident and CIDP, a Girl Shows her Courage
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
CIDP Treatment Shows Evidence of Progress in New Study
Source: Pixabay

CIDP Treatment Shows Evidence of Progress in New Study

Earlier this month, The Lancet Neurology published results from its PATH study (Polyneuropathy And Treatment with Hizentra), which showed efficacy in treating people with chronic inflammatory demyelinating polyneuropathy (CIDP). Great news and hope…

Continue Reading CIDP Treatment Shows Evidence of Progress in New Study